Page 7 - Convertible Security News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Convertible security. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Convertible Security Today - Breaking & Trending Today

Deepak Fertilizers to consider conversion of FCCBs


On 01 July 2021Deepak Fertilizers & Petrochemicals Corp will consider and approve on 01 July 2021 the conversion of Foreign Currency Convertible Bonds (FCCBs) issued to International Finance Corporation (IFC) into equity shares of the Company consequent to exercise of conversion right available to them pursuant to FCCB Subscription Agreement entered between
the Company and IFC.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to re ....

International Finance Corporation , Deepak Fertilizers Petrochemicals Corp , Petrochemicals Corp , Foreign Currency Convertible Bonds , Capital Market , Foreign Currency Convertible Bonds , International Finance Corporation , Convertible Bond , Convertible Security , Investment Holding Companies Nec , International Finance Corporation Ifc , Eepak Fertilizers Amp Petrochemicals , சர்வதேச நிதி நிறுவனம் , தீபக் உரங்கள் பெட்ரோ கெமிக்கல்ஸ் கார்ப் , பெட்ரோ கெமிக்கல்ஸ் கார்ப் , வெளிநாட்டு நாணய மாற்றத்தக்கது பத்திரங்கள் , மூலதனம் சந்தை ,

Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results


Helix BioPharma Corp. Announces Fiscal Third Quarter 2021 Results
OVERVIEW
The Company reported a net loss and total comprehensive loss of $2,554,000 and $5,268,000 for the three and nine-month periods ended April 30, 2021. For the three and nine-month periods ended April 30, 2020, net loss and total comprehensive loss totalled $2,489,000 and $6,896,000, respectively. The net loss and total comprehensive loss for the three-month period ending April 30, 2021, includes a net loss of $nil (2020 - $198,000) and for the nine-month period ending April 30, 2021 a gain of $1,536,000 (2020 - loss of $465,000) from discontinued operations. The Company lost control of its subsidiary in Poland during the three-month period ending October 31, 2020 though continued to exert significant influence until December 22, 2020 when the Company disposed of its remaining interest for gross proceeds of $2,308,000. ....

Richmond Hill , Frank Michalargias , Pascal Nigen , Helix Biopharma Corp , Company Interim Condensed Statement Of Financial Position , Company Interim Condensed Financial , Fund Management , Moffit Cancer Centre , Alpha Bronze , Company Interim Condensed Statement Of Net Loss , Lind Global Macro Fund , Helix Biopharma , Investigational New Drug , Multijurisdictional Disclosure System , Accounting Oversight Board , Consulting Management , Convertible Security , Interim Condensed Statement , Net Loss , Comprehensive Loss , Condensed Statements , Financial Position , Interim Condensed Financial Statements , Chief Financial , Looking Statements , Annual Information Form ,